Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Make a Passover gift and support Jewish journalism. DONATE NOW
Fast Forward

Rochelle Shoretz, Founder of Sharsheret and Cancer Advocate, Dies at 42

Rochelle Shoretz, whose own breast cancer diagnosis at age 28 led her to found the national cancer organization Sharsheret, died Sunday at her home in Teaneck, New Jersey. She was 42. The cause of death was complications from breast cancer.

Shoretz founded Sharsheret in 2001, while undergoing chemotherapy. The organization provides health information and support services for Jewish women living with breast cancer or ovarian cancer, or who are at increased risk for those diseases.

Jewish women of Ashkenazi descent are at heightened risk for certain genetic mutations that can lead to cancer.

A graduate of Columbia Law School, Shoretz went on to clerk for United States Supreme Court Justice Ruth Bader Ginsburg. She is thought to be the first Orthodox Jewish woman to clerk for a Supreme Court justice.

“When I was diagnosed [in July 2001], there were a lot of offers to help with meals and transport my kids, but I really wanted to speak to another young mom who was going to have to explain to her kids that she was going to lose her hair to chemo,” Shoretz told JTA in 2003, of her decision to start Sharsheret.

The organization’s name is Hebrew for chain.

Shoretz beat her initial bout with the disease. But in 2009, the cancer returned, and it had spread. No longer curable, it was treatable — and friends say her energy and resolve were boundless until the end.

Shoretz is survived by two teenage sons, Shlomo and Dovid Mirsky; her mother, Sherry Tenenbaum; her father, Morris Shoretz; five sisters, and two brothers. She was a stepdaughter of Jeffrey Tenenbaum and Carol Ann Finkelstein.

A funeral and interment will be held Monday in New Jersey.

This is a moment of great uncertainty. Here’s what you can do about it.

We hope you appreciated this article. Before you go, we’d like to ask you to please support the Forward’s independent Jewish news this Passover. All donations are being matched by the Forward Board - up to $100,000.

This is a moment of great uncertainty for the news media, for the Jewish people, and for our sacred democracy. It is a time of confusion and declining trust in public institutions. An era in which we need humans to report facts, conduct investigations that hold power to account, tell stories that matter and share honest discourse on all that divides us.

With no paywall or subscriptions, the Forward is entirely supported by readers like you. Every dollar you give this Passover is invested in the future of the Forward — and telling the American Jewish story fully and fairly.

The Forward doesn’t rely on funding from institutions like governments or your local Jewish federation. There are thousands of readers like you who give us $18 or $36 or $100 each month or year.

Support our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines.
You must comply with the following:

  • Credit the Forward
  • Retain our pixel
  • Preserve our canonical link in Google search
  • Add a noindex tag in Google search

See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.